HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Govt to End Observational Avigan Study for COVID-19
January 5, 2022
-
BUSINESS 5 Atopic Dermatitis Drugs Debut in Japan since 2018; Focus Now on Roles of Dupixent, JAK Inhibitors
December 28, 2021
-
TRENDS 15 APIs with 10 Billion Yen-Plus Peak Sales Outlooks Listed in 2021: Jiho Tally
December 28, 2021
-
TRENDS Top 10 PHARMA JAPAN Articles in 2021
December 28, 2021
-
REGULATORY Japan Approves Lenvima/Keytruda Pair, Opdivo Label Expansion
December 27, 2021
-
REGULATORY Japan Approves MSD’s Oral COVID-19 Drug Molnupiravir
December 27, 2021
-
REGULATORY Ronapreve Given to Nearly 37,000 People in Japan by November, Xevudy to 270: MHLW
December 24, 2021
-
REGULATORY Japan Seeks Additional Study for Aducanumab, Next Review Might Be Few Years Off
December 23, 2021
-
REGULATORY Gist of FY2022 Drug Pricing Reform
December 22, 2021
-
REGULATORY Japan Likely to Expand PMP Coverage for Add’l Indications, Set 4-Year Grace Period for Spillover Exclusion: 2022 Reform
December 21, 2021
-
COMMENTARY Japan Unlikely to Introduce Medical Fee Incentives for Hospital Formularies in FY2022 Reform
December 20, 2021
-
BUSINESS Astellas to Abolish Pay Structure for Sales Reps, Switching to Company-Wide System Next April
December 20, 2021
-
BUSINESS Pfizer Agrees to Supply Oral COVID-19 Drugs for 2 Million People in Japan
December 20, 2021
-
BUSINESS Biogen to Challenge European Rejection of Aducanumab
December 20, 2021
-
BUSINESS Moderna to Develop All Global Pipeline Assets in Japan without Delay: Local Chief
December 17, 2021
-
BUSINESS Shionogi Pharma Eyes 10 Billion Yen Sales in CDMO Business in FY2022
December 17, 2021
-
REGULATORY Japan Approves Moderna Vaccine for COVID-19 Booster
December 16, 2021
-
REGULATORY Japan Panel OKs Moderna COVID-19 Vaccine for Booster Use
December 16, 2021
-
REGULATORY Aducanumab Up for Japan Advisory Panel Review on December 22
December 15, 2021
-
REGULATORY MHLW Calls for Lifting of Shipment Restrictions for 130 Generic API/Specifications after Survey Finds YOY Rise in Supplies
December 14, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
